H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

Date: March 15, 2016
Pages: 63
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H8D90408445EN
Leaflet:

Download PDF Leaflet

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

H. Lundbeck A/S (Lundbeck), a subsidiary of The Lundbeck Foundation, is a pharmaceutical company, which carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of to the central nervous system (CNS) related diseases. Its products are used in the treatment of diseases such as depression, anxiety, psychotic diseases, alcohol dependence, epilepsy and Huntington’s disease, Alzheimer’s disease and Parkinson’s disease. Lundbeck has production and research facilities in China, Denmark, France, Italy and the US. It operates through its subsidiaries and markets its products across the world. Lundbeck is headquartered in Valby, Denmark.

H. Lundbeck AS Key Recent Developments

Nov 04, 2015: Lundbeck: Financial report for the period 1 January to 30 September2015
Sep 09, 2015: GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members
Aug 19, 2015: Major restructuring to regain profitability and ensure value creation
Aug 07, 2015: Lundbeck Joins Innovative Alzheimer’s Disease Research Initiative
May 06, 2015: H. Lundbeck: Solid performance in the first quarter of the year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

H. Lundbeck A/S - Key Facts
H. Lundbeck A/S - Key Employees
H. Lundbeck A/S - Key Employee Biographies
H. Lundbeck A/S - Major Products and Services
H. Lundbeck A/S - Pharmaceutical Pipeline Products Data
H. Lundbeck A/S, Pipeline Products by Therapy Area
H. Lundbeck A/S, Pipeline Products by Development Phase
H. Lundbeck A/S - History
H. Lundbeck A/S - Company Statement
H. Lundbeck A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

H. Lundbeck A/S - Business Description
H. Lundbeck A/S - Corporate Strategy
H. Lundbeck A/S - SWOT Analysis
SWOT Analysis - Overview
H. Lundbeck A/S - Strengths
Strength - Strong Presence - Central Nervous System
Strength - Sturdy Research and Development Activities
H. Lundbeck A/S - Weaknesses
Weakness - Product Discontinuations
Weakness - Operational Performance
Weakness - Declining Cash Reserves
H. Lundbeck A/S - Opportunities
Opportunity - Pipeline Products
Opportunity - Regulatory Approvals and Product launches
Opportunity - Restructuring Initiatives
H. Lundbeck A/S - Threats
Threat - Cost Containment Pressures
Threat - Intense Competition
Threat - Stringent Government Regulations
H. Lundbeck A/S - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
H. Lundbeck A/S, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 04, 2015: Lundbeck: Financial report for the period 1 January to 30 September2015
Sep 09, 2015: GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members
Aug 19, 2015: Major restructuring to regain profitability and ensure value creation
Aug 07, 2015: Lundbeck Joins Innovative Alzheimer’s Disease Research Initiative
May 06, 2015: Kare Schultz appointed new president and CEO of Lundbeck
May 06, 2015: H. Lundbeck: Solid performance in the first quarter of the year
Apr 14, 2015: Lundbeck and Keep Memory Alive Invest to Support Multiple System Atrophy Research and Global Taskforce

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

H. Lundbeck A/S, Key Facts
H. Lundbeck A/S, Key Employees
H. Lundbeck A/S, Key Employee Biographies
H. Lundbeck A/S, Major Products and Services
H. Lundbeck A/S, Number of Pipeline Products by Therapy Area
H. Lundbeck A/S, Number of Pipeline Products by Development Stage
H. Lundbeck A/S, Pipeline Products By Therapy Area and Development Phase
H. Lundbeck A/S, History
H. Lundbeck A/S, Subsidiaries
H. Lundbeck A/S, Key Competitors
H. Lundbeck A/S, Ratios based on current share price
H. Lundbeck A/S, Annual Ratios
H. Lundbeck A/S, Interim Ratios
H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
H. Lundbeck A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

H. Lundbeck A/S, Pipeline Products by Therapy Area
H. Lundbeck A/S, Pipeline Products by Development Phase
H. Lundbeck A/S, Performance Chart (2011 - 2015)
H. Lundbeck A/S, Ratio Charts
H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: